Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Total Debt (2018 - 2025)

Dna X's Total Debt history spans 7 years, with the latest figure at $171000.0 for Q4 2025.

  • Quarterly results put Total Debt at $171000.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $171000.0 (changed N/A YoY), and the annual figure for FY2025 was $171000.0, changed.
  • Total Debt for Q4 2025 was $171000.0 at Dna X, down from $250000.0 in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $566000.0 in Q1 2025 to a low of $37000.0 in Q3 2023.
  • The 4-year median for Total Debt is $181000.0 (2022), against an average of $209714.3.
  • The sharpest move saw Total Debt crashed 96.88% in 2021, then fell 26.69% in 2022.
  • Year by year, Total Debt stood at $214000.0 in 2021, then crashed by 31.31% to $147000.0 in 2022, then crashed by 74.83% to $37000.0 in 2023, then surged by 362.16% to $171000.0 in 2025.
  • According to Business Quant data, Total Debt over the past three periods came in at $171000.0, $250000.0, and $566000.0 for Q4 2025, Q3 2025, and Q1 2025 respectively.